SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-076476
Filing Date
2024-06-24
Accepted
2024-06-24 09:18:16
Documents
11
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K eras-20240620.htm   iXBRL 8-K 47168
  Complete submission text file 0000950170-24-076476.txt   163958

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20240620.xsd EX-101.SCH 25792
14 EXTRACTED XBRL INSTANCE DOCUMENT eras-20240620_htm.xml XML 4879
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 241062244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)